Androgen receptor-mediated CD8 T cell stemness programs drive sex differences in antitumor immunity.

Yang C, Jin J, Yang Y, Sun H, Wu L, Shen M, Hong X, Li W, Lu L, Cao D, et al. Androgen receptor-mediated CD8 T cell stemness programs drive sex differences in antitumor immunity. Immunity. 2022.